Home > Insider Trading > Filing (0001062993-19-003653)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
875622	Biospecifics Technologies Corp	BSTC	Pharmaceutical Preparations (2834)	113054851

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1405128	Toby Wegman	C/O Biospecifics Technologies Corp. 35 Wilbur Street Lynbrook NY 11563		Yes	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock, $0.001 Par Value	Disposition	2019-09-09	1,100	$55.23	943,973	No	4	S	Indirect	See footnote
Common Stock, $0.001 Par Value	Disposition	2019-09-10	8,900	$55.16	935,073	No	4	S	Indirect	See footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	See footnote
No	4	S	Indirect	See footnote

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock, $0.001 Par Value	1,890	Direct

Footnotes

The selling price of $55.23 is reflective of the weighted average sale price of all transactions reported on this line. The prices for the transactions reported on this line range from $55.20 to $55.35. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
The selling price of $55.16 is reflective of the weighted average sale price of all transactions reported on this line. The prices for the transactions reported on this line range from $55.00 to $55.44. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
These shares are held in trust on behalf of the reporting person. The reporting person is the trustee of the trust. The reporting person disclaims beneficial ownership of the shares held by the trust except to the extent of the reporting person's pecuniary interest therein.